21 May 2019
Simplifying your FFR procedure
Sponsored by GE Healthcare
                        Chairperson: 
                                            N.H. Pijls
                        Panellists: 
                                            E. Barbato,                                             K.G. Oldroyd
                        
                                                                                    
                            
                        
                                                    Summary
Consult this session to learn all about the latest techniques in FFR, to choose the appropriate hyperaemic agent and to know more about the use of regadenoson (Rapiscan).
Learning Objectives
- To understand latest techniques in FFR
- To choose appropriate hyperaemic agent for use in FFR
- To learn about use of regadenoson (Rapiscan) as a hyperaemic agent
 
                     
                     
    
/slide001.jpg) 
                /slide002.jpg) 
                /slide003.jpg) 
                /slide004.jpg) 
                /slide005.jpg) 
                /slide006.jpg) 
                /slide007.jpg) 
                /slide008.jpg) 
                
/slide001.jpg) 
                /slide002.jpg) 
                /slide003.jpg) 
                /slide004.jpg) 
                /slide005.jpg) 
                /slide006.jpg) 
                /slide007.jpg) 
                /slide008.jpg) 
                /slide009.jpg) 
                /slide010.jpg) 
                /slide011.jpg) 
                /slide012.jpg) 
                /slide013.jpg) 
                /slide014.jpg) 
                /slide015.jpg) 
                /slide016.jpg) 
                /slide017.jpg) 
                /slide018.jpg) 
                /slide019.jpg) 
                /slide020.jpg) 
                /slide021.jpg) 
                /slide022.jpg) 
                /slide023.jpg) 
                /slide024.jpg) 
                /slide025.jpg) 
                /slide026.jpg) 
                
/slide001.jpg) 
                /slide002.jpg) 
                /slide003.jpg) 
                /slide004.jpg) 
                /slide005.jpg) 
                /slide006.jpg) 
                /slide007.jpg) 
                /slide008.jpg) 
                /slide009.jpg) 
                /slide010.jpg) 
                /slide011.jpg) 
                /slide012.jpg) 
                /slide013.jpg) 
                /slide014.jpg) 
                /slide015.jpg) 
                /slide016.jpg) 
                /slide017.jpg) 
                /slide018.jpg) 
                /slide019.jpg) 
                /slide020.jpg) 
                /slide021.jpg) 
                /slide022.jpg) 
                /slide023.jpg) 
                /slide024.jpg) 
                /slide025.jpg) 
                /slide026.jpg) 
                /slide001.jpg) 
                /slide002.jpg) 
                /slide003.jpg) 
                /slide004.jpg) 
                /slide005.jpg) 
                /slide006.jpg) 
                /slide007.jpg) 
                /slide008.jpg) 
                /slide009.jpg) 
                /slide010.jpg) 
                /slide011.jpg) 
                /slide012.jpg) 
                /slide013.jpg) 
                /slide014.jpg) 
                /slide015.jpg) 
                /slide016.jpg) 
                /slide017.jpg) 
                /slide018.jpg) 
                /slide019.jpg) 
                /slide020.jpg) 
                /slide021.jpg) 
                /slide022.jpg) 
                /slide001.jpg) 
                /slide002.jpg) 
                /slide003.jpg) 
                /slide004.jpg) 
                /slide005.jpg)